Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific
Authors
Keywords
-
Journal
Journal of Fungi
Volume 9, Issue 2, Pages 241
Publisher
MDPI AG
Online
2023-02-13
DOI
10.3390/jof9020241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial
- (2022) Laurence Millon et al. CLINICAL INFECTIOUS DISEASES
- Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
- (2022) Francesca Raffaelli et al. Journal of Fungi
- A Multiplex PCR and DNA-Sequencing Workflow on Serum for the Diagnosis and Species Identification for Invasive Aspergillosis and Mucormycosis
- (2022) S. Imbert et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
- (2021) Matteo Rinaldi et al. Transplant Infectious Disease
- In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles
- (2021) Andrew M. Borman et al. Journal of Fungi
- COVID-19 and mucormycosis superinfection: the perfect storm
- (2021) Jaffar A. Al-Tawfiq et al. INFECTION
- ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
- (2021) Shivaprakash M. Rudramurthy et al. MYCOSES
- Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021
- (2021) Olivia Bupha‐Intr et al. INTERNAL MEDICINE JOURNAL
- Breakthrough Invasive Fungal Infections: Who is at risk?
- (2020) Jeffrey D. Jenks et al. MYCOSES
- EUCAST susceptibility testing of isavuconazole: MIC data for contemporary clinical mould and yeast isolates
- (2019) Karin Meinike Jørgensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients
- (2019) Frederic Lamoth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- A new species concept for the clinically relevant Mucor circinelloides complex
- (2019) L. Wagner et al. PERSOONIA
- Species Identification and Delineation of Pathogenic Mucorales by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
- (2018) Jin Shao et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
- (2017) Romuald Bellmann et al. INFECTION
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species
- (2015) Anuradha Chowdhary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent
- (2015) Jeffrey M. Rybak et al. PHARMACOTHERAPY
- Epidemiology of mucormycosis in Europe
- (2014) G. Petrikkos et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
- (2014) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries
- (2014) P.E. Verweij et al. JOURNAL OF CHEMOTHERAPY
- DNA barcoding in Mucorales: an inventory of biodiversity
- (2013) G. Walther et al. PERSOONIA
- Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme
- (2012) Michael A. Pfaller et al. MYCOPATHOLOGIA
- Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
- (2011) A. Skiada et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial
- (2011) Brad Spellberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales
- (2011) Roxana G. Vitale et al. JOURNAL OF CLINICAL MICROBIOLOGY
- AMBIZYGO : étude de phase II de l’efficacité d’une posologie initiale élevée d’amphotéricine B liposomale (AmBisome®) [10 mg/kg/j] dans le traitement des zygomycoses
- (2008) F. Lanternier et al. MEDECINE ET MALADIES INFECTIEUSES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started